816438-46-7 Usage
Description
3-(4-Chlorobutyl)indoline-5-carbonitrile is an organic compound that serves as a key intermediate in the synthesis of pharmaceuticals. It is characterized by its unique molecular structure, which includes an indoline core with a chlorobutyl and carbonitrile functional groups attached. 3-(4-Chlorobutyl)indoline-5-carbonitrile plays a crucial role in the development of certain medications, particularly in the field of mental health.
Uses
Used in Pharmaceutical Industry:
3-(4-Chlorobutyl)indoline-5-carbonitrile is used as a reactant for the preparation of the antidepressant drug Vilazodone (V265000). It contributes to the formation of the drug's active ingredient, which is designed to help alleviate symptoms of depression and anxiety disorders. 3-(4-Chlorobutyl)indoline-5-carbonitrile's presence in the synthesis process is essential for creating an effective and well-tolerated medication for patients suffering from mood disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 816438-46-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,1,6,4,3 and 8 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 816438-46:
(8*8)+(7*1)+(6*6)+(5*4)+(4*3)+(3*8)+(2*4)+(1*6)=177
177 % 10 = 7
So 816438-46-7 is a valid CAS Registry Number.
816438-46-7Relevant articles and documents
INDOLE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS
-
Page/Page column 23-24, (2008/06/13)
Disclosed are compounds of formula (I), the use thereof for producing a medicament utilized for treating diseases related to the serotonin receptor and/or serotonin reuptake, especially for producing a medicament utilized as an anxiolytic, antidepressant, neuroleptic, and/or antihypertensive and/or for positively influencing obsessive-compulsive behavior (OCD), sleeping disorders, tardive dyskinesia, learning disorders, age-related memory defects, eating disorders such as bulimia, and/or sexual dysfunctions. The inventive compounds bond to the 5-HT1A receptor.
